News: ChroMedX Strengthens Board of DirectorsAnother director just added to strengthen its business development and commercialization team...
"I am very excited to formally join the ChroMedX team." said Dr. Richard Janeczko, Director, ChroMedX Corp. "The HemoPalm is a game-changer in the application of point-of-care diagnostics to improved management of critically ill patients. It represents the next logical step in the evolution of diagnosis in this area which began over 15 years ago. I believe that it will allow even better outcomes for patients because it combines the analyses and results-output for both blood gases and co-oximetry on a single, hand-held device and it will achieve this in the shortest possible time. With HemoPalm, ChroMedX has responded to a well-recognized need for rapid, comprehensive and accurate testing for critical care medicine and I look forward to what the future has to bring."
More here:
https://www.stockhouse.com/news/press-releases/2017/12/07/chromedx-strengthens-board-of-directors-with-the-appointment-of-dr-richard